- The UAE BioTech Symposium will be hosted in partnership with
AmCham Abu Dhabi's BioTech Committee and Masdar City
- The UAE BioTech Symposium will attract U.S. and international
BioTech owners and executives exploring opportunities in the
rapidly growing BioTech sector in Abu
Dhabi
- The inaugural symposium will be followed by quarterly events
with Roadshow destinations across the Middle East
ABU
DHABI, UAE, Sept. 18,
2024 /PRNewswire/ -- Secondcell Bio, a U.S. BioTech
company scaling-up the its platform technology invented at
The Rockefeller University in the
United Arab Emirates, is pleased
to invite U.S. and international BioTech owners and executives to
participate in the inaugural UAE BioTech Symposium, in partnership
with AmCham Abu Dhabi's BioTech Committee and Masdar City, taking
place on November 6-8, 2024 in Masdar
City, Abu Dhabi.
Further details regarding the symposium and registration
information may be found at
https://www.uaebiotechsymposium.com.
The exclusive event focusing on advancing the biotechnology
sector in Abu Dhabi, UAE is
expected to attract approximately 150 qualified attendees
interested in exploring opportunities in the rapidly growing
BioTech and Life Sciences sector in the UAE. The symposium will
offer an unparalleled platform to foster collaboration, innovation,
growth and catalyze progress within the sector among entrepreneurs,
researchers, governmental representatives and strategic investors.
The inaugural symposium will be followed by quarterly events at
destinations across the Middle
East.
"Abu Dhabi and
Dubai attract the best of the
best worldwide. Our forum is for BioTech owners and company
builders. Join the adventure, #comeridewithme!" says Dr.
Kambiz Shekdar, Chairman of the
event and recipient of the first BioTech Inventor Golden Visa via a
nomination from Abu Dhabi Competitive Office (COAD) who has
transitioned to Abu Dhabi with
support from Abu Dhabi Investment Office (ADIO)/Abu Dhabi Residents
Office (ADRO), "If even the UAE invests a tiny fraction of its
wealth, we can move from Oil to Medicine."
The symposium will be held at Masdar City, a pioneering
sustainable urban community and world-class business and technology
hub that has cultivated a thriving ecosystem of leading global
organizations dedicated to evolving research and innovation:
As the leading Life Sciences cluster hub in Abu Dhabi, Masdar City is proud to host a
rapidly growing number of 55 companies across key clusters such as
Basic Research, Pre-Clinical Research, Clinical Trials, and
Logistics and Service Delivery. Pioneering organizations like the
region's first Biobank, Attentive Sciences, G42, Insilico Medicine
and the Emirates Drug Establishment are part of our growing
ecosystem have chosen Masdar City due to its supportive ecosystem
which contributes to cutting-edge advancements in the life sciences
sector industry.
In close collaboration with key government entities such as the
Department of Health (DOH), the Abu Dhabi Investment Office (ADIO),
and the Abu Dhabi Department of Economic Development (ADDED), we
are fully aligned with Abu Dhabi's
vision for a knowledge-based economy. Masdar City Free Zone offers
the right ecosystem, with unparalleled incentives, a strategic
location, and a dynamic environment that empowers businesses to
excel and deliver lasting impact both locally and globally.
United States Ambassador to the
United Arab Emirates Martina Strong, whom Dr. Shekdar first met at
AmCham Abu Dhabi's ADIPEC Kick-Off Dinner in 2023, has expressed
her possible interest in making our US-UAE initiative an 'ABC'
(America, Britain, Canada) initiative. UAE BioTech Symposium
wishes to go one step further: We invite BioTech pioneers from
around the world to come join us as the exciting new BioTech and
Life Sciences sector takes root and flourishes in Abu Dhabi and throughout the region.
AmCham Abu Dhabi CEO, Liz Beneski
will provide opening remarks for the symposium, which is the first
forum of its kind in the region. The symposium will provide
attendees the opportunity to hear from distinguished international
experts as well as founding members of the AmCham Abu Dhabi BioTech
Committee. Key discussion topics will include growth of the BioTech
sector across various regions, Emirati genomic research initiatives
and the future of medicine in the UAE.
Networking opportunities will be available for BioTech sector
leaders to gather, discuss and explore potential areas of
collaboration along with exclusive immersive visits to local
laboratories and research hospitals in Abu Dhabi and Dubai for an
up-close view of the cutting-edge capabilities and facilities in
the UAE.
"It has been a privilege working alongside Dr. Shekdar where his
expertise and genuine altruistic dedication to advancing science
for the benefit of all humanity have been invaluable in inspiring
our team to advance our organizational objectives," says
Fabienne Duchini of Secondcell Bio,
"Under Dr. Shekdar's visionary leadership, the symposium will offer
novel insights and a compelling vision for the future of BioTech. I
hope you will join us to see all of what the UAE has to offer."
Several UAE government-linked entities will have information
available about their services and business incentives for
companies looking to expand to the UAE, including Masdar City, Abu
Dhabi Investment Office, Abu Dhabi Residents Office and
[LIST-IN-FORMATION].
The symposium will offer an optional weekend program featuring a
variety of cultural, leisure and lifestyle experiences in
Abu Dhabi and Dubai. The
weekend activities have been selected by luxury travel agency
2xceed Destination Management to enable participants to explore all
that these two Emirati destinations have to offer outside the
official program.
We are grateful for the support of our generous corporate
sponsors and exhibitors. Sponsors include Halia Therapeutics and
Innova Therapeutics. International knowledge partners and corporate
exhibitors include Jones Lang LaSalle Inc. (JLL), AtkinsRéalis,
GRÜNECKER Patent Attorneys and Attorneys-at-Law, Sartorius Stedim
Biotech GmbH, BioTech Clusters and university technology transfer
offices [LIST-IN-FORMATION].
PRESS BRIEFINGS
We invite members of the press to learn more. Private one-on-one
briefings are available for scheduling as follows:
1) Members of UAE and GCC press: 10am to
8pm, Monday September 16,
2024, 10am to 8pm, Monday
September 23, 2024 and 10am to 8pm,
Monday October 7, 2024, GCC Time
Zone
2) Business & technology press: 7am to
5pm, Tuesday October 8, 2024,
EST Time Zone
3) All members of the press: 10am to
10pm, Wednesday October 9,
2024, GCC Time Zone
To schedule a private one-on-one press briefing, please
contact Fabienne Duchini at
fabienne.duchini@secondcellbio.com.
At a closed-door press briefing, Dr. Shekdar will share his
personal experience navigating business opportunities in the UAE,
adapting to the culture and his impression of the opportunities and
challenges for others considering the move. We encourage members of
the media including business press, U.S. and local outlets to join
for a firsthand account of his experience pioneering a new sector
of the knowledge based economy in the most mature market in the
Arab Gulf States.
Additional information for members of the press is available
here:
https://www.prnewswire.com/news-releases/abu-dhabi-to-host-new-quarterly-forum-to-attract-us-biotech-firms-302248957.html
About UAE BioTech Symposium
UAE BioTech Symposium in
partnership with the AmCham Abu Dhabi BioTech Committee and Masdar
City will host quarterly panel discussions and lab tours in
Abu Dhabi, Dubai and
roadshow destinations throughout the GCC and Middle East. The events are free with
attendance limited to prioritize U.S. and international BioTech
owners and executives. Program details will be posted online in
Arabic and in English as registration for each event goes live via
the AmCham Abu Dhabi website.
Arabic site for scientific program:
http://www.uaebiotechsymposium.ae
English site for scientific program:
https://www.uaebiotechsymposium.com
About AmCham Abu Dhabi
AmCham Abu Dhabi (the trademark
of the American Business Group of Abu
Dhabi) is a member of the global network of American
Chambers of Commerce. Active since 1986, AmCham Abu Dhabi's Mission
is to promote commerce, investment, and goodwill between its
membership, the United States of
America and the United Arab
Emirates. Our vision is to be an innovative organization
creating trusted commercial partnerships that broaden U.S. - U.A.E.
relationships. AmCham Abu Dhabi is an independent, not-for-profit
association, comprised of Fortune 500 corporations, small and
medium sized companies and prominent business leaders and
entrepreneurs. For more information, visit:
https://amchamabudhabi.org/
About Masdar City
Masdar City is a pioneering
sustainable urban community, a world-class business
and technology hub, and a "green-print" for cities that want
to be part of the solution to climate change. With one of the
largest clusters of LEED Platinum buildings in the world, we
are dedicated to creating a new kind of city, a new way of
working and living, and a more sustainable future for
everyone.
The Masdar City Free Zone is a diverse, innovative, and
ambitious group of over 1,000 organizations that benefit from
comprehensive business support as well as the city's
rich ecosystem. Tenants include the International Renewable
Energy Agency (IRENA), the UAE Space Agency, Siemens Energy, G42,
the Advanced Technology Research Council, several Fortune 500
companies, and the Mohamed bin Zayed University of Artificial
Intelligence. The Masdar City Free Zone also includes The Catalyst,
a clean-tech start-up investor powered by both Masdar City and
BP.
Masdar City hosts a growing residential community and has
piloted two generations of autonomous vehicles. It also
manages the Masdar Green REIT, a real estate investment
trust dedicated to investing in sustainable real estate
assets. Currently the Masdar Green REIT is worth nearly AED
2.9 billion. https://masdarcity.ae/
About AmCham Abu Dhabi BioTech Committee
The AmCham
BioTech Committee was formed to establish a BioTech sector in
Abu Dhabi with a focus on
promoting opportunities for U.S. BioTech companies with a vision to
be a thought leader and facilitator for U.S. corporate interests in
the emerging BioTech sector in Abu
Dhabi and throughout the Middle
East. Since its founding, the BioTech committee has seen a
notable uptick in interest from U.S.-based companies seeking to
broaden their service offerings within the region. AmCham BioTech
Committee founding members include Seconcell Bio, Intelligenix
Advanced Diagnostics, Extend Biosciences, Halia Therapeutics and
Jones Lang LaSalle Inc (JLL).
https://amchamabudhabi.org/biotech/
AMCHAM ABU DHABI BIOTECH
COMMITTEE FOUNDING MEMBERS
About Secondcell Bio
Secondcell Bio™ is building
public-private partnerships worldwide to scale-up the demonstrated
and largely automated platform biotechnology originating from
The Rockefeller University. The company
was formed by Dr. Kambiz Shekdar,
PhD, inventor of Chromovert® Technology. Secondcell Bio owns
Chromovert® Technology. https://www.secondcellbio.com/
About Intelligenix Advanced Diagnostics
Intelligenix
Advanced Diagnostics is a biotechnology company currently
developing novel diagnostic and therapeutic technology for breast
and prostate cancer under the rubrics of personalized and precision
medicine. Intelligenix AD is developing cutting-edge,
targeted therapeutics and companion diagnostic tests that encompass
five critical areas: 1) determining cancer risk, 2) cancer
early detection and diagnosing, 3) determining the best course of
treatment, 4) molecular-based therapeutics, and 5) monitoring
treatment effectiveness. Intelligenix Advanced Diagnostic's
technology aims to significantly advance cancer disease management
via its impressive patented technology platform, which covers these
critical areas for precision medicine and ultimately improves
patient outcomes and survival rates.
https://intelligenix-adx.com/
About Extend Biosciences
Extend Biosciences Inc. is a
clinical stage biotechnology company developing a novel drug
delivery platform technology (D-VITylation®) that significantly
improves the pharmacokinetic properties of peptides and proteins.
The Company's lead D-VITylated drug candidate, EXT608, targets the
rare disease Hypoparathyroidism (HPT) characterized by
inappropriately low circulating levels of parathyroid hormone
(PTH). EXT608 is being developed as a subcutaneously
self-administered once-weekly dosing regimen for improved patient
compliance and superior efficacy. Phase 2 trials in patients are
underway. https://extendbio.com/
About Halia Therapeutics
Halia Therapeutics is a
clinical-stage biopharmaceutical company dedicated to developing
innovative therapies for neuroinflammation, metabolic diseases, and
chronic inflammation. Through a unique approach targeting
inflammatory pathways, Halia aims to deliver groundbreaking
treatments to improve patient outcomes in areas of high unmet
medical need. https://haliatx.com/
About Jones Lang LaSalle Inc. (JLL) / JLL MENA / JLL
Healthcare and Lifsciences
For over 200 years, JLL (NYSE:
JLL), a leading global commercial real estate and investment
management company, has helped clients buy, build, occupy, manage
and invest in a variety of commercial, industrial, hotel,
residential and retail properties. A Fortune 500 company with
annual revenue of $20.8 billion and
operations in over 80 countries around the world, our more than
108,000 employees bring the power of a global platform combined
with local expertise. Driven by our purpose to shape the future of
real estate for a better world, we help our clients, people and
communities SEE A BRIGHTER WAYSM. JLL is the brand name, and a
registered trademark, of Jones Lang LaSalle Incorporated. For
further information, visit https://www.us.jll.com/
JLL MEA. Across the Middle
East and Africa (MEA) JLL
is a leading player in the real estate and hospitality services
markets. The firm has worked in 35 countries across the region and
employs over 1900 internationally qualified professionals across
its offices in Dubai, Abu Dhabi, Riyadh, Jeddah, Al Khobar, Cairo, Casablanca, Cape
Town, Johannesburg and
Nairobi.
https://www.jll-mena.com/en
JLL Healthcare and Lifesciences. JLL's Healthcare and
Life Sciences consulting team offers a global network of experts
with extensive regional expertise. We provide best-in-class
advisory services for companies in these sectors, including
feasibility studies, market entry and expansion strategies,
technical and commercial due diligence. Our comprehensive
consulting services help clients navigate complex challenges in the
healthcare and life sciences industries.
AMCHAM ABU DHABI BIOTECH
COMMITTEE NEW MEMBERS
About Innova Therapeutics
Innova Therapeutics is a
biopharmaceutical company developing a monoclonal antibody (mAb)
platform targeting a novel protein that is highly expressed in both
solid and hematological cancers. Innova's platform technology is
initially focused on targeting cancers including pediatric
osteosarcoma, sarcomas, triple negative breast cancer, multiple
myeloma and pancreatic cancer. Current cancer therapies only target
either the tumors directly or one component of the tumor
microenvironment, while the pathway targeted with our therapy
impacts both the tumor and tumor microenvironment simultaneously
through a common pathway. In addition, a diagnostic is in
development which has the tremendous potential for early cancer
detection, as well as a prognostic marker for assessing therapeutic
benefit of treatments and assessment of potential reoccurrence of
cancer. https://www.innovatherapeutics.com/
UAE BioTech Symposium Cultural, Tourism and Logistics
Partner
About 2xceed Destination Management
2xceed delivers
bespoke luxury travel, event planning, and corporate services with
a focus on exceptional local expertise in UAE and all Middle East, innovative itineraries, and VIP
experiences. Their offerings include tailored holidays, special
event access, meetings & incentives, congress management, and
comprehensive event logistics, all while adhering to principles of
sustainability and corporate social responsibility.
https://www.2xceed.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/secondcell-bio-to-chair-uae-biotech-symposium-in-masdar-city-abu-dhabi-302252396.html
SOURCE Secondcell Bio, LLC; UAE BioTech Symposium